Andrea Burden

Professor
Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Switzerland

Poster(s):

• (114) Are Women with Rheumatoid Arthritis Really Less Likely to Achieve Remission with Biologics? A Cohort Study in The Swiss Clinical Quality Management Cohort
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (65) Biological Disease-Modifying Antirheumatic Drugs and Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis: A Danish Cohort Study with Prevalent New-User Design
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (40) Bayesian Nonparametric Comorbidity Analysis of Type 2 Diabetes Mellitus (T2DM)
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (X) Age and Sex Differences in Polypharmacy Patterns in New Users of Metformin: A UK-Based Descriptive Study
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (122) Personalized Prescribing in Type 2 Diabetes Following The 2015 UK Treatment Guidelines: Description of Non-Insulin Anti-Diabetic Drug (NIAD) Utilization and Polypharmacy Patterns
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (290) Outcome Misclassification: Differences in Hip Fracture Identification Using Administrative Claims Data
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST